1. Home
  2. YSXT vs SKYE Comparison

YSXT vs SKYE Comparison

Compare YSXT & SKYE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • YSXT
  • SKYE
  • Stock Information
  • Founded
  • YSXT 2011
  • SKYE 2012
  • Country
  • YSXT China
  • SKYE United States
  • Employees
  • YSXT N/A
  • SKYE N/A
  • Industry
  • YSXT Automotive Aftermarket
  • SKYE Biotechnology: Pharmaceutical Preparations
  • Sector
  • YSXT Consumer Discretionary
  • SKYE Health Care
  • Exchange
  • YSXT Nasdaq
  • SKYE Nasdaq
  • Market Cap
  • YSXT 87.9M
  • SKYE 80.7M
  • IPO Year
  • YSXT 2024
  • SKYE N/A
  • Fundamental
  • Price
  • YSXT $2.60
  • SKYE $3.14
  • Analyst Decision
  • YSXT
  • SKYE Buy
  • Analyst Count
  • YSXT 0
  • SKYE 6
  • Target Price
  • YSXT N/A
  • SKYE $18.67
  • AVG Volume (30 Days)
  • YSXT 74.7K
  • SKYE 178.7K
  • Earning Date
  • YSXT 01-01-0001
  • SKYE 02-18-2025
  • Dividend Yield
  • YSXT N/A
  • SKYE N/A
  • EPS Growth
  • YSXT N/A
  • SKYE N/A
  • EPS
  • YSXT 0.21
  • SKYE N/A
  • Revenue
  • YSXT $58,546,729.00
  • SKYE N/A
  • Revenue This Year
  • YSXT N/A
  • SKYE N/A
  • Revenue Next Year
  • YSXT N/A
  • SKYE N/A
  • P/E Ratio
  • YSXT $11.08
  • SKYE N/A
  • Revenue Growth
  • YSXT 18.92
  • SKYE N/A
  • 52 Week Low
  • YSXT $2.06
  • SKYE $2.31
  • 52 Week High
  • YSXT $6.27
  • SKYE $19.41
  • Technical
  • Relative Strength Index (RSI)
  • YSXT N/A
  • SKYE 52.82
  • Support Level
  • YSXT N/A
  • SKYE $2.70
  • Resistance Level
  • YSXT N/A
  • SKYE $3.29
  • Average True Range (ATR)
  • YSXT 0.00
  • SKYE 0.45
  • MACD
  • YSXT 0.00
  • SKYE 0.05
  • Stochastic Oscillator
  • YSXT 0.00
  • SKYE 41.27

About YSXT YSX Tech. Co. Ltd Class A Ordinary Shares

YSX Tech Co Ltd provide business solutions to enterprise customers, mainly insurance companies and brokerages, in China. The company has three operating segments: Auto Insurance Aftermarket Value-added Services, Other Scenario-based Customized Services and Software Development and Information Technology Services. Key revenue is generated from Auto Insurance Aftermarket Value-added Services segment which include four types value added services: vehicle safety inspection and check services, vehicle driving risk screening services, designated driver and rescue services and vehicle maintenance and other value-added services.

About SKYE Skye Bioscience Inc. Common Stock

Skye Bioscience Inc is a pre-clinical pharmaceutical company located in San Diego, California. The company's clinical assets focus on the modulation of cannabinoid receptor 1 ("CB1") to provide novel treatments and alternatives for diseases caused by metabolic disorders, inflammation, fibrosis and neurodegeneration, such as obesity and glaucoma. The company's Phase 2 clinical candidates include nimacimab, a negative allosteric modulating antibody that inhibits peripheral CB1 receptors, currently being developed for the treatment of obesity and SBI-100 Ophthalmic Emulsion ("SBI-100 OE"), a CB1 agonist (activator), currently being developed for the treatment of glaucoma and ocular hypertension.

Share on Social Networks: